Physician profile
Edward Cahill
NPI 1831155878
$654.60
in general payments reported to CMS, 2019-2025
13 companies · $56.02 in 2025
The $56.02 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $59.66 · 2021: $32.36 · 2022: $87.18 · 2023: $158 · 2024: $85.70 · 2025: $56.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $166.11 | 2019-2024 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $138.64 | 2019-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $68.71 | 2023-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $59.78 | 2019-2023 | Doc Band |
| Ironshore Pharmaceuticals INC. | $44.00 | 2020-2021 | |
| Adlon Therapeutics L.P. | $39.45 | 2019 | |
| Kaleo, INC. | $21.58 | 2022 | |
| Neos Therapeutics, LP | $20.78 | 2023 | Adzenys Xr-Odt |
| Pfizer INC. | $20.67 | 2024 | |
| Sanofi Pasteur INC. | $19.26 | 2023 | |
| Collegium Pharmaceutical, INC. | $19.01 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $18.33 | 2019 | |
| Vyne Pharmaceuticals INC. | $18.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.